ANZ considers $600 million sale

The company is focusing on taking its own brand into Asia, rather than holding stakes in other banks.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ANZ (ASX: ANZ) is said to be holding discussions with Japans Mizuho Financial Group for the sale of its 39.2% stake in Bank Pan Indonesia.

The company believes its stake of Indonesia's seventh-largest bank is worth $668 million but was an inheritance of former management. However with new liquidity requirements enforced by the Australian Prudential Regulation Authority, CEO Mike Smith said the bank will review its stake in a number of small holdings. "The treatment under Basel III or under APRA's definition of Basel III with regard to partnerships is something we have to look at". Mr Smith said in April.

Since January 2012, the company has sold two minority stakes in Asian banks and funnelled the money back into its fully owned subsidiaries in China and other banks such as PT ANZ, a 99%-owned subsidiary that has experienced large revenue growth since ANZ began its Super Regional Strategy in 2007.

ANZ's strategy of bringing competition to Asian banks is somewhat different to Westpac (ASX: WBC) or NAB's (ASX: NAB) approach. While ANZ seeks to produce 25%-30% of revenues from its APEA division by 2017, its two Australian rivals are happy to take advantage of trade flows to and from Australia.

Foolish takeaway

Currently, this Fool thinks that Aussie banks are overpriced and investors could find higher growth and better yield ideas outside the top 20 ASX stocks.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Owen Raszkiewicz owns shares in Cochlear, Challenger and Leighton Holdings.  

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »